白三烯受体的药理学特性 - Suppr

Pharmacological characterization of leukotriene receptors.

作者信息

Dahlén S E

机构信息

Experimental Asthma and Allergy Research, National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

出版信息

Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 2):S41-5. doi: 10.1164/ajrccm.161.supplement_1.ltta-9.

DOI:10.1164/ajrccm.161.supplement_1.ltta-9

PMID:10673225

Abstract

摘要

相似文献

Pharmacological characterization of leukotriene receptors.

Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 2):S41-5. doi: 10.1164/ajrccm.161.supplement_1.ltta-9.

Antileukotriene treatment in children with asthma--new patents.

Recent Pat Inflamm Allergy Drug Discov. 2008 Nov;2(3):202-11. doi: 10.2174/187221308786241938.

Leukotriene B4 inhibitors: US2009054466; US2009227603 and US2009253684.

Expert Opin Ther Pat. 2010 May;20(5):707-14. doi: 10.1517/13543771003657180.

[Leukotrienes and antagonists of leukotriene receptors].

J Pharm Belg. 1997 May-Jun;52(3):131-2.

Blockade of avidity and focal clustering of beta 2-integrin by cysteinyl leukotriene antagonism attenuates eosinophil adhesion.

J Allergy Clin Immunol. 2007 Dec;120(6):1316-23. doi: 10.1016/j.jaci.2007.07.038. Epub 2007 Sep 29.

Should antihistamines be re-considered as antiasthmatic drugs as adjuvants to anti-leukotrienes?

Eur J Pharmacol. 2013 Feb 15;701(1-3):181-4. doi: 10.1016/j.ejphar.2013.01.009. Epub 2013 Jan 23.

[Antileukotriene drugs: a new treatment for asthma].

Boll Chim Farm. 1999 Dec;138(11):599-605.

[May the Force be with antileukotriene drugs].

Pneumonol Alergol Pol. 2010;78(1):1-2.

Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.

J Pharmacol Exp Ther. 2005 Feb;312(2):432-40. doi: 10.1124/jpet.104.074922. Epub 2004 Oct 6.

[New developments in asthma therapy: how do individual leukotriene antagonists work?].

Praxis (Bern 1994). 1998 Feb 18;87(8):271-5.

引用本文的文献

Targeting cell signaling in allergic asthma.

Signal Transduct Target Ther. 2019 Oct 18;4:45. doi: 10.1038/s41392-019-0079-0. eCollection 2019.

Integrating evidence for managing asthma in patients who smoke.

Allergy Asthma Immunol Res. 2014 Mar;6(2):114-20. doi: 10.4168/aair.2014.6.2.114. Epub 2014 Feb 17.

Foxa2 regulates leukotrienes to inhibit Th2-mediated pulmonary inflammation.

Am J Respir Cell Mol Biol. 2013 Dec;49(6):960-70. doi: 10.1165/rcmb.2013-0122OC.

Pranlukast: a review of its use in the management of asthma.

Drugs. 2003;63(10):991-1019. doi: 10.2165/00003495-200363100-00005.

Montelukast: a review of its therapeutic potential in asthma in children 2 to 14 years of age.

Paediatr Drugs. 2002;4(2):123-39. doi: 10.2165/00128072-200204020-00005.

An alternative pathway for metabolism of leukotriene D(4): effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea.

Br J Pharmacol. 2001 Aug;133(7):1134-44. doi: 10.1038/sj.bjp.0704180.

Montelukast: a review of its therapeutic potential in persistent asthma.

Drugs. 2000 Apr;59(4):891-928. doi: 10.2165/00003495-200059040-00015.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Pharmacological characterization of leukotriene receptors.

Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 2):S41-5. doi: 10.1164/ajrccm.161.supplement_1.ltta-9.

Antileukotriene treatment in children with asthma--new patents.

Recent Pat Inflamm Allergy Drug Discov. 2008 Nov;2(3):202-11. doi: 10.2174/187221308786241938.

Leukotriene B4 inhibitors: US2009054466; US2009227603 and US2009253684.

Expert Opin Ther Pat. 2010 May;20(5):707-14. doi: 10.1517/13543771003657180.

[Leukotrienes and antagonists of leukotriene receptors].

J Pharm Belg. 1997 May-Jun;52(3):131-2.

Blockade of avidity and focal clustering of beta 2-integrin by cysteinyl leukotriene antagonism attenuates eosinophil adhesion.

J Allergy Clin Immunol. 2007 Dec;120(6):1316-23. doi: 10.1016/j.jaci.2007.07.038. Epub 2007 Sep 29.

Should antihistamines be re-considered as antiasthmatic drugs as adjuvants to anti-leukotrienes?

Eur J Pharmacol. 2013 Feb 15;701(1-3):181-4. doi: 10.1016/j.ejphar.2013.01.009. Epub 2013 Jan 23.

[Antileukotriene drugs: a new treatment for asthma].

Boll Chim Farm. 1999 Dec;138(11):599-605.

[May the Force be with antileukotriene drugs].

Pneumonol Alergol Pol. 2010;78(1):1-2.

Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.

J Pharmacol Exp Ther. 2005 Feb;312(2):432-40. doi: 10.1124/jpet.104.074922. Epub 2004 Oct 6.

[New developments in asthma therapy: how do individual leukotriene antagonists work?].

Praxis (Bern 1994). 1998 Feb 18;87(8):271-5.

引用本文的文献

Targeting cell signaling in allergic asthma.

Signal Transduct Target Ther. 2019 Oct 18;4:45. doi: 10.1038/s41392-019-0079-0. eCollection 2019.

Integrating evidence for managing asthma in patients who smoke.

Allergy Asthma Immunol Res. 2014 Mar;6(2):114-20. doi: 10.4168/aair.2014.6.2.114. Epub 2014 Feb 17.

Foxa2 regulates leukotrienes to inhibit Th2-mediated pulmonary inflammation.

Am J Respir Cell Mol Biol. 2013 Dec;49(6):960-70. doi: 10.1165/rcmb.2013-0122OC.

Pranlukast: a review of its use in the management of asthma.

Drugs. 2003;63(10):991-1019. doi: 10.2165/00003495-200363100-00005.

Montelukast: a review of its therapeutic potential in asthma in children 2 to 14 years of age.

Paediatr Drugs. 2002;4(2):123-39. doi: 10.2165/00128072-200204020-00005.

An alternative pathway for metabolism of leukotriene D(4): effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea.

Br J Pharmacol. 2001 Aug;133(7):1134-44. doi: 10.1038/sj.bjp.0704180.

Montelukast: a review of its therapeutic potential in persistent asthma.

Drugs. 2000 Apr;59(4):891-928. doi: 10.2165/00003495-200059040-00015.

Pharmacological characterization of leukotriene receptors.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献